Semaglutide, which is the active ingredient in Novo Nordisk's Wegovy and Ozempic, as well as tirzepatide, which is the active ingredient in Eli Lily's Mounjaro and Zepbound, are considered GLP-1 drugs
Up to 12% of Americans are already taking these drugs (known as incretin mimetics), and that number is only expected to rise
Quick fixes tend to be short-lived, he says, emphasizing the importance of lifestyle intervention through nutrition and exercise
Serious side effects are rare, but you should seek urgent medical help if you experience: To help manage mild nausea, eat smaller meals, avoid high-fat foods, and drink plenty of water
The key during this phase is consistency
Provides a more bioavailable form of L-carnitine and helps the body produce energy